Silibinin exerts cancer chemopreventive efficacy via targeting prostate cancer cell and cancer-associated fibroblast interaction

Prostate cancer (PCA) kills thousands in the US each year despite massive investment and success in improving early detection and treatment. Importantly, even successful treatment is still associated with persistent and often highly disruptive adverse health effects on the patient. As a consequence,... View More